Amneal Pharmaceuticals logo

Amneal Pharmaceuticals share price today

(AMRX)

Amneal Pharmaceuticals share price is $7.85 & ₹668.50 as on 25 Dec 2024, 2.30 'hrs' IST

$7.85

0.06

(0.77%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Amneal Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Amneal Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Amneal Pharmaceuticals. Get details on the Indian mutual funds that are investing in Amneal Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Amneal Pharmaceuticals's financials.

Amneal Pharmaceuticals share price movements

  • Today's Low: $7.74
    Today's High: $7.93

    Day's Volatility :2.41%

  • 52 Weeks Low: $5.01
    52 Weeks High: $9.48

    52 Weeks Volatility :47.12%

Amneal Pharmaceuticals Returns

PeriodAmneal Pharmaceuticals Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-6.59%
-10.0%
0.0%
6 Months
20.4%
-5.7%
0.0%
1 Year
32.71%
2.8%
0.0%
3 Years
53.05%
-0.4%
-21.1%

Amneal Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$7.79
Open
$7.79
Today's High
$7.93
Today's Low
$7.7385
Market Capitalization
$3.6B
Today's Volume
$599.2K
52 Week High
$9.475
52 Week Low
$5.01
Revenue TTM
$2.7B
EBITDA
$566.8M
Earnings Per Share (EPS)
$-0.86
Profit Margin
-6.88%
Quarterly Earnings Growth YOY
-0.75%
Return On Equity TTM
-185.77%

How to invest in Amneal Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Amneal Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Amneal Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Amneal Pharmaceuticals or AMRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Amneal Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Amneal Pharmaceuticals shares which would translate to 0.108 fractional shares of Amneal Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Amneal Pharmaceuticals, in just a few clicks!

Returns in Amneal Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Amneal Pharmaceuticals investment value today

Current value as on today

₹1,36,130

Returns

₹36,130

(+36.13%)

Returns from Amneal Pharmaceuticals Stock

₹33,731 (+33.73%)

Dollar Returns

₹2,399 (+2.4%)

Indian investors sentiment towards Amneal Pharmaceuticals

13%

Period: Sep 25, 2024 to Dec 24, 2024. Change in 30 Days versus previous period

Search volume for Amneal Pharmaceuticals on INDmoney from India has grown in the last 30 days as on Dec 25, 2024. 13% more investors are searching Amneal Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Amneal Pharmaceuticals

  • UBS Group AG

    7.03%

  • Vanguard Group Inc

    4.72%

  • TPG GP A, LLC

    3.98%

  • BlackRock Inc

    3.64%

  • Rubric Capital Management LP

    3.46%

  • Citadel Advisors Llc

    2.87%

Analyst Recommendation on Amneal Pharmaceuticals

Buy

    81%Buy

    9%Hold

    9%Sell

Based on 11 Wall street analysts offering stock ratings for Amneal Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
1
1
1
Sell
1
1
1

Analyst Forecast on Amneal Pharmaceuticals

What analysts predicted

Upside of 33.76%

Current:

$7.85

Target:

$10.50

Insights on Amneal Pharmaceuticals

  • Price Movement

    In the last 1 year, AMRX stock has moved up by 35.2%
  • Increasing Revenue

    Revenue is up for the last 4 quarters, 616.98M → 702.46M (in $), with an average increase of 4.2% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 5.99M → -156.0K (in $), with an average decrease of 102.6% per quarter

Amneal Pharmaceuticals Financials in INR & Dollars

FY18Y/Y Change
Revenue
$1.7B
↑ 60.88%
Net Income
$-169.7M
↓ 201.24%
Net Profit Margin
-10.21%
↓ 26.43%
FY19Y/Y Change
Revenue
$1.6B
↓ 2.2%
Net Income
$-603.6M
↑ 255.62%
Net Profit Margin
-37.11%
↓ 26.9%
FY20Y/Y Change
Revenue
$2.0B
↑ 22.51%
Net Income
$68.6M
↓ 111.36%
Net Profit Margin
3.44%
↑ 40.55%
FY21Y/Y Change
Revenue
$2.1B
↑ 5.08%
Net Income
$20.2M
↓ 70.59%
Net Profit Margin
0.96%
↓ 2.48%
FY22Y/Y Change
Revenue
$2.2B
↑ 5.67%
Net Income
$-254.8M
↓ 1363.21%
Net Profit Margin
-11.52%
↓ 12.48%
FY23Y/Y Change
Revenue
$2.4B
↑ 8.2%
Net Income
$-84.0M
↓ 67.03%
Net Profit Margin
-3.51%
↑ 8.01%
Q2 FY23Q/Q Change
Revenue
$599.0M
↑ 7.44%
Net Income
$11.9M
↓ 218.06%
Net Profit Margin
1.99%
↑ 3.8%
Q3 FY23Q/Q Change
Revenue
$620.0M
↑ 3.5%
Net Income
$9.7M
↓ 18.75%
Net Profit Margin
1.56%
↓ 0.43%
Q4 FY23Q/Q Change
Revenue
$617.0M
↓ 0.49%
Net Income
$-98.6M
↓ 1118.89%
Net Profit Margin
-15.99%
↓ 17.55%
Q1 FY24Q/Q Change
Revenue
$659.2M
↑ 6.84%
Net Income
$-91.6M
↓ 7.1%
Net Profit Margin
-13.9%
↑ 2.09%
Q2 FY24Q/Q Change
Revenue
$701.8M
↑ 6.46%
Net Income
$6.0M
↓ 106.54%
Net Profit Margin
0.85%
↑ 14.75%
Q3 FY24Q/Q Change
Revenue
$702.5M
↑ 0.1%
Net Income
$-156.0K
↓ 102.6%
Net Profit Margin
-0.02%
↓ 0.87%
FY18Y/Y Change
Profit
$716.4M
↑ 36.15%
FY19Y/Y Change
Profit
$353.0M
↓ 50.73%
FY20Y/Y Change
Profit
$628.4M
↑ 78.02%
FY21Y/Y Change
Profit
$769.0M
↑ 22.37%
FY22Y/Y Change
Profit
$784.7M
↑ 2.05%
FY23Y/Y Change
Profit
$820.6M
↑ 4.57%
Q2 FY23Q/Q Change
Profit
$220.0M
↑ 23.48%
Q3 FY23Q/Q Change
Profit
$232.5M
↑ 5.69%
Q4 FY23Q/Q Change
Profit
$189.8M
↓ 18.36%
Q1 FY24Q/Q Change
Profit
$238.1M
↑ 25.41%
Q2 FY24Q/Q Change
Profit
$249.9M
↑ 4.99%
Q3 FY24Q/Q Change
Profit
$269.6M
↑ 7.85%
FY18Y/Y Change
Operating Cash Flow
$250.2M
↑ 6.85%
Investing Cash Flow
$-396.4M
↑ 302.19%
Financing Cash Flow
$287.7M
↓ 402.77%
FY19Y/Y Change
Operating Cash Flow
$1.7M
↓ 99.32%
Investing Cash Flow
$-19.6M
↓ 95.06%
Financing Cash Flow
$-45.8M
↓ 115.93%
FY20Y/Y Change
Operating Cash Flow
$379.0M
↑ 22128.8%
Investing Cash Flow
$-317.5M
↑ 1521.79%
Financing Cash Flow
$131.8M
↓ 387.58%
FY21Y/Y Change
Operating Cash Flow
$241.8M
↓ 36.2%
Investing Cash Flow
$-194.2M
↓ 38.85%
Financing Cash Flow
$-138.1M
↓ 204.79%
FY22Y/Y Change
Operating Cash Flow
$65.1M
↓ 73.08%
Investing Cash Flow
$-174.3M
↓ 10.23%
Financing Cash Flow
$-106.6M
↓ 22.81%
Q2 FY23Q/Q Change
Operating Cash Flow
$-11.3M
↓ 108.12%
Investing Cash Flow
$-12.3M
↑ 4.66%
Financing Cash Flow
$-12.3M
↓ 4.99%

Amneal Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Amneal Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Amneal Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Amneal Pharmaceuticals Inc.
-7.04%
20.4%
32.71%
53.05%
72.73%
Neurocrine Biosciences Inc.
7.77%
0.85%
4.42%
62.14%
26.33%
Haleon Plc Spon Ads
1.46%
14.35%
18.54%
31.17%
31.17%
Zoetis Inc.
-8.07%
-3.87%
-15.97%
-33.36%
23.29%
Viatris Inc.
-6.51%
19.75%
16.62%
-8.63%
-23.56%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Amneal Pharmaceuticals Inc.
89.83
NA
NA
0.61
-1.86
0.06
NA
-0.3
Neurocrine Biosciences Inc.
36.53
36.53
0.32
6.37
0.16
0.12
NA
26.87
Haleon Plc Spon Ads
28.5
28.5
1.73
0.34
0.07
0.04
0.02
1.82
Zoetis Inc.
30.99
30.99
2.56
5.88
0.47
0.15
0.01
11.59
Viatris Inc.
224.4
NA
0.08
2.69
-0.04
0.02
0.04
16.58
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Amneal Pharmaceuticals Inc.
Buy
$3.6B
72.73%
89.83
-6.88%
Neurocrine Biosciences Inc.
Buy
$13.9B
26.33%
36.53
17.21%
Haleon Plc Spon Ads
Buy
$43.8B
31.17%
28.5
10.75%
Zoetis Inc.
Buy
$74.4B
23.29%
30.99
26.55%
Viatris Inc.
Hold
$14.9B
-23.56%
224.4
-5.87%

About Amneal Pharmaceuticals

an american pharmaceutical company, amneal develops and produces affordable medicines. the company was built upon a family tradition of quality and integrity. everything amneal does, across the full spectrum of its business, is in service to these guiding principles. amneal is committed to constantly elevating and refining the value it delivers to its customers and patients around the globe.
Organization
Amneal Pharmaceuticals
Employees
7850
CEO
Mr. Chirag K. Patel
Industry
Health Technology

Management People of Amneal Pharmaceuticals

NameTitle
Mr. Chirag K. Patel
Co-Founder, Co-CEO, President & Director
Mr. Chintu Patel R.Ph.
Co-Founder, Co-CEO & Director
Mr. Anastasios G. Konidaris
Executive VP & CFO
Mr. Jason B. Daly Esq.
Senior VP, Chief Legal Officer & Corporate Secretary
Ms. Nikita Shah
Executive VP & Chief Human Resources Officer
Mr. Andrew S. Boyer
Executive VP & Chief Commercial Officer of Generics
Mr. Anthony DiMeo
Head of Investor Relations
Mr. Gregory Sgammato
Senior Vice President of Corporate Development
Mr. Pranav Mehta
Senior VP of Strategic Sourcing & Supply Management
Dr. Sanjay Kumar Jain Ph.D.
Chief Quality Officer

Important FAQs about investing in Amneal Pharmaceuticals from India :

What is Amneal Pharmaceuticals share price today?

Amneal Pharmaceuticals share price today stands at $7.85, Open: $7.79 ; Previous Close: $7.79 ; High: $7.93 ; Low: $7.74 ; 52 Week High: $9.48 ; 52 Week Low: $5.01. The stock opens at $7.79, after a previous close of $7.79. The stock reached a daily high of $7.93 and a low of $7.74, with a 52-week high of $9.48 and a 52-week low of $5.01.

Can Indians buy Amneal Pharmaceuticals shares?

Yes, Indians can invest in the Amneal Pharmaceuticals (AMRX) from India.

With INDmoney, you can buy Amneal Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Amneal Pharmaceuticals at zero transaction cost.

How can I buy Amneal Pharmaceuticals shares from India?

It is very easy to buy Amneal Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Amneal Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Amneal Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Amneal Pharmaceuticals stocks?

To start investing in Amneal Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Amneal Pharmaceuticals

Today’s highest price of Amneal Pharmaceuticals (AMRX) is $7.93.

Today’s lowest price of Amneal Pharmaceuticals (AMRX) is $7.74.

What is today's market capitalisation of Amneal Pharmaceuticals

Today's market capitalisation of Amneal Pharmaceuticals AMRX is 3.6B

What is the 52 Week High and Low Range of Amneal Pharmaceuticals

  • 52 Week High

    $9.48

  • 52 Week Low

    $5.01

What are the historical returns of Amneal Pharmaceuticals?

  • 1 Month Returns

    -7.04%

  • 3 Months Returns

    20.4%

  • 1 Year Returns

    32.71%

  • 5 Years Returns

    72.73%

Who is the Chief Executive Officer (CEO) of Amneal Pharmaceuticals

Mr. Chirag K. Patel is the current Chief Executive Officer (CEO) of Amneal Pharmaceuticals.